Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations

被引：0

作者：

Gee-Chen Chang

David Chi-Leung Lam

Chun-Ming Tsai

Yuh-Min Chen

Jin-Yuan Shih

Shyam Aggarwal

Shuhang Wang

Sang-We Kim

Young-Chul Kim

Ibrahim Wahid

Rubi Li

Darren Wan-Teck Lim

Virote Sriuranpong

Raymond Tsz-Tong Chan

Robert M. Lorence

Philippe Carriere

Christina Raabe

Agnieszka Cseh

Keunchil Park

机构：

[1] Taichung Veterans General Hospital,Division of Chest Medicine, Department of Internal Medicine

[2] Chung Shan Medical University Hospital,Division of Pulmonary Medicine, Department of Internal Medicine

[3] Chung Shan Medical University,Institute of Medicine and School of Medicine

[4] Queen Mary Hospital,Department of Chest Medicine

[5] The University of Hong Kong,Asan Medical Center

[6] Taipei Veterans General Hospital,Samsung Medical Center

[7] Taipei Veterans General Hospital,undefined

[8] and School of Medicine,undefined

[9] National Yang-Ming Medical University,undefined

[10] National Taiwan University Hospital,undefined

[11] Sir Ganga Ram Hospital Rajinder Nagar,undefined

[12] Beijing Cancer Hospital,undefined

[13] University of Ulsan College of Medicine,undefined

[14] Chonnam National University,undefined

[15] Hwasun Hospital,undefined

[16] Beacon International Specialist Centre,undefined

[17] St Luke’s Medical Center,undefined

[18] National Cancer Centre,undefined

[19] Chulalongkorn University and the King Chulalongkorn Memorial Hospital,undefined

[20] Hong Kong Pacific Centre,undefined

[21] Boehringer Ingelheim Pharmaceuticals,undefined

[22] Inc.,undefined

[23] Boehringer Ingelheim International GmbH,undefined

[24] Boehringer Ingelheim RCV GmBH & Co. KG,undefined

[25] Sungkyunkwan University School of Medicine,undefined

来源：

International Journal of Clinical Oncology | 2021年 / 26卷

关键词：

Afatinib; mutations; Lung cancer; Named patient use; NSCLC; Uncommon ; mutations;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：841 / 850

页数：9

共 50 条

[41] Improvement in Overall Survival in a Randomized Study That Compared Dacomitinib With Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer and EGFR-Activating Mutations [J].

Mok, Tony S. ;

Cheng, Ying ;

Zhou, Xiangdong ;

Lee, Ki Hyeong ;

Nakagawa, Kazuhiko ;

Niho, Seiji ;

Lee, Min ;

Linke, Rolf ;

Rosell, Rafael ;

Corral, Jesus ;

Migliorino, Maria Rita ;

Pluzanski, Adam ;

Sbar, Eric I. ;

Wang, Tao ;

White, Jane Liang ;

Wu, Yi-Long .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (22) :2244-+

[42] Budget impact of sequential treatment with first-line afatinib versus first-line osimertinib in non-small-cell lung cancer patients with common EGFR mutations [J].

Lotte Westerink ;

Jelmer L. J. Nicolai ;

Carl Samuelsen ;

Hans J. M. Smit ;

Pieter E. Postmus ;

Ingolf Griebsch ;

Maarten J. Postma .

The European Journal of Health Economics, 2020, 21 :931-943

[43] Budget impact of sequential treatment with first-line afatinib versus first-line osimertinib in non-small-cell lung cancer patients with common EGFR mutations [J].

Westerink, Lotte ;

Nicolai, Jelmer L. J. ;

Samuelsen, Carl ;

Smit, Hans J. M. ;

Postmus, Pieter E. ;

Griebsch, Ingolf ;

Postma, Maarten J. .

EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2020, 21 (06) :931-943

[44] OUTCOMES OF AFATINIB-BASED REGIMENS FOR SALVAGE TREATMENT OF ADVANCED STAGE NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS WHO HAD BEEN HEAVILY PRETREATED [J].

Tsai, Chun-Ming ;

Chiu, Chao-Hua ;

Chiang Chi-Lu ;

Huang, Ya-Chi ;

Chang, Kuo-Ting .

JOURNAL OF THORACIC ONCOLOGY, 2013, 8 :S610-S611

[45] Afatinib versus cisplatin plus pemetrexed in Japanese patients with advanced non-small cell lung cancer harboring activating EGFR mutations: Subgroup analysis of LUX-Lung 3 [J].

Kato, Terufumi ;

Yoshioka, Hiroshige ;

Okamoto, Isamu ;

Yokoyama, Akira ;

Hida, Toyoaki ;

Seto, Takashi ;

Kiura, Katsuyuki ;

Massey, Dan ;

Seki, Yoko ;

Yamamoto, Nobuyuki .

CANCER SCIENCE, 2015, 106 (09) :1202-1211

[46] A phase II, multicenter, two cohort study of 160 mg osimertinib in EGFR T790M-positive non-small-cell lung cancer patients with brain metastases or leptomeningeal disease who progressed on prior EGFR TKI therapy [J].

Park, S. ;

Lee, M-H ;

Seong, M. ;

Kim, S. T. ;

Kang, J-H ;

Cho, B. C. ;

Lee, K. H. ;

Cho, E. K. ;

Sun, J-M ;

Lee, S-H ;

Ahn, J. S. ;

Park, K. ;

Ahn, M-J .

ANNALS OF ONCOLOGY, 2020, 31 (10) :1397-1404

[47] The efficacy and toxicity of afatinib in advanced EGFR-positive non-small-cell lung cancer patients after failure of first-generation tyrosine kinase inhibitors: a systematic review and meta-analysis [J].

Zhang, Yaxiong ;

Miao, Siyu ;

Wang, Fang ;

Fang, Wenfeng ;

Chen, Gang ;

Chen, Xi ;

Yan, Fang ;

Huang, Xiaodan ;

Wu, Manli ;

Huang, Yan ;

Zhang, Li .

JOURNAL OF THORACIC DISEASE, 2017, 9 (07) :1980-1987

[48] Re: Two centres' experience with lung cancer resection in patients with advanced non-small-cell lung cancer following treatment with immune checkpoint inhibitors: safety and clinical outcomes [J].

Mennecier, Bertrand ;

Olland, Anne ;

Mascaux, Celine ;

Falcoz, Pierre-Emmanuel .

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2021, 60 (06) :1306-1307

[49] Afatinib and Dacomitinib Efficacy, Safety, Progression Patterns, and Resistance Mechanisms in Patients with Non-Small Cell Lung Cancer Carrying Uncommon EGFR Mutations: A Comparative Cohort Study in China (AFANDA Study) [J].

Li, Hong-Shuai ;

Wang, Shou-Zheng ;

Xu, Hai-Yan ;

Yan, Xiang ;

Zhang, Jin-Yao ;

Lei, Si-Yu ;

Li, Teng ;

Hao, Xue-Zhi ;

Zhang, Tao ;

Yang, Guang-Jian ;

Zhou, Li-Qiang ;

Liu, Peng ;

Wang, Yu-Ying ;

Hu, Xing-Sheng ;

Xing, Pu-Yuan ;

Wang, Yan .

CANCERS, 2022, 14 (21)

[50] Effect of Dose Adjustments on the Safety and Efficacy of Afatinib in Chinese Patients with EGFR- Mutated Non-Small Cell Lung Cancer Who Participated in the LUX-Lung Clinical Trial Program [J].

Tu, Hai-Yan ;

Wu, Yi-Long .

ONCOTARGETS AND THERAPY, 2020, 13 :12539-12547

← 1 2 3 4 5 →